What is NDC 42571-374?

42571-374 is the product NDC for Lincomycin, Lincomycin hydrochloride 300 mg/mL injection, solution, listed with the FDA by Micro Labs Limited. It has 4 package NDCs, shown above in 10- and 11-digit form.

Micro Labs Limited, NDC labeler code 42571. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Lincomycin?

9 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Lincomycin NDC 42571-374 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)42571-374Labeler and product segments. Claims need a package NDC.

Product NDC at billing width42571-0374Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
42571-374-75	4257103747542571037475	1 VIAL in 1 CARTON (42571-374-75) / 2 mL in 1 VIALMarketed from Feb 1, 2022
42571-374-88	4257103748842571037488	1 VIAL in 1 CARTON (42571-374-88) / 10 mL in 1 VIALMarketed from Feb 1, 2022
42571-374-89	4257103748942571037489	10 VIAL in 1 CARTON (42571-374-89) / 10 mL in 1 VIALMarketed from Aug 1, 2026
42571-374-91	4257103749142571037491	10 VIAL in 1 CARTON (42571-374-91) / 2 mL in 1 VIALMarketed from Aug 1, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Lincomycin
Generic name (nonproprietary): lincomycin
Active ingredients: Lincomycin hydrochloride — 300 mg/mL
Dosage form: Injection, Solution
Route: Intramuscular, Intravenous
Labeler: Micro Labs LimitedNDC labeler code 42571
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 215082
Marketing start: Feb 1, 2022
Listing expires: Dec 31, 2027
Identifiers: Product ID 42571-374_5834c892-22e9-1e32-e063-6294a90a0ae5SPL ID 5834c892-22e9-1e32-e063-6294a90a0ae5SPL set ID 20c0e8af-a78f-47f8-ace4-06b80def7003RxCUI 239212UNII M6T05Z2B68UPC 0342571374891, 0342571374914

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N442571037475 followed by a unit qualifier and the quantity

Package 42571-0374-75. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 4, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Lincomycin injection is indicated in the treatment of serious infections due to susceptible strains of streptococci, pneumococci, and staphylococci. Its use should be reserved for penicillin-allergic patients or other patients for whom, in the judgment of the physician, a penicillin is inappropriate. Because of the risk of CDAD, as described in the BOXED WARNING , before selecting lincomycin the physician should consider the nature of the infection and the suitability of other alternatives. Indicated surgical procedures should be performed in conjunction with antibacterial therapy. Lincomycin injection may be administered concomitantly with other antimicrobial agents wh…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 42571-374

What is NDC 42571-374?: 42571-374 is the product NDC for Lincomycin, Lincomycin hydrochloride 300 mg/mL injection, solution, listed with the FDA by Micro Labs Limited. It has 4 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Lincomycin.
What is the active ingredient?: Lincomycin hydrochloride.
Who is the labeler?: Micro Labs Limited, NDC labeler code 42571. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Lincomycin?: 9 other product NDCs are listed under this name. See all Lincomycin NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Lincomycin NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Lincomycinlincomycin hydrochloride	Lincomycin hydrochloride 3000 mg/10mL	InjectionIntramuscular, Intravenous	PAI Holdings, LLC dba PAI Pharma	0121-1035	00121-1035-55
Lincomycin	Lincomycin hydrochloride 600 mg/2mL	Injection, SolutionIntramuscular, Intravenous	Armas Pharmaceuticals Inc.	72485-114	72485-0114-01
Lincomycin	Lincomycin hydrochloride 3000 mg/10mL	Injection, SolutionIntramuscular, Intravenous	Armas Pharmaceuticals Inc.	72485-115	72485-0115-10
Lincomycinlincomycin hydrochloride	Lincomycin hydrochloride 300 mg/mL	Injection, SolutionIntramuscular, Intravenous, Subconjunctival	Sagent Pharmaceuticals	25021-193	25021-0193-0225021-0193-10
lincomycin	Lincomycin 300 mg/mL	Injection, SolutionIntramuscular, Intravenous	Slate Run Pharmaceuticals, LLC	70436-034	70436-0034-82
lincomycin	Lincomycin 300 mg/mL	Injection, SolutionIntramuscular, Intravenous	Slate Run Pharmaceuticals, LLC	70436-035	70436-0035-8070436-0035-82
Lincomycinlincomycin hydrochloride	Lincomycin hydrochloride 300 mg/mL	Injection, SolutionIntramuscular, Intravenous, Subconjunctival	Henry Schein, Inc.	0404-9901	00404-9901-10
Lincomycinlincomycin hydrochloride	Lincomycin hydrochloride 300 mg/mL	Injection, SolutionIntramuscular, Intravenous, Subconjunctival	XGen Pharmaceuticals DJB, Inc.	39822-0350	39822-0350-02
Lincomycinlincomycin hydrochloride	Lincomycin hydrochloride 300 mg/mL	Injection, SolutionIntramuscular, Intravenous, Subconjunctival	XGen Pharmaceuticals DJB, Inc.	39822-0353	39822-0353-06

Other NDCs under ANDA 215082

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 215082
Product	Strength	Form · route	Labeler	Product NDC
Lincomycin	Lincomycin hydrochloride 600 mg/2mL	Injection, SolutionIntramuscular, Intravenous	Armas Pharmaceuticals Inc.	72485-114
Lincomycin	Lincomycin hydrochloride 3000 mg/10mL	Injection, SolutionIntramuscular, Intravenous	Armas Pharmaceuticals Inc.	72485-115